How could gene therapy change the way we treat age-related macular degeneration?
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in individuals over 50 years of age [1]. Advanced AMD can anatomically present as either neovascular (nAMD) or a...
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A higher rate of significant adverse effects, linked to inflammatory events, were reported in patients with diabetic macular edema (INFINITY trial) compared to neovascular age-related macular degeneration (OPTIC trial), despite patients receiving the same therapeutic vector and dose.17,18”
From Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age (2025) · cites this paper as [17]
Citations
Cites
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926 · cited 1×
“the delivery of gene therapy in trials [8].”
BackgroundBennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300389 · Cited by 267
Review of gene therapies for age-related macular degeneration
Khanani, A. M., Thomas, M. J., Aziz, A. A., Weng, C. Y., Danzig, C. J., Yiu, G., Kiss, S., Waheed, N. K., & Kaiser, P. K. (2022) · Eye · doi:10.1038/s41433-021-01842-1 · Cited by 119
Self-citationComplement cascade inhibition in geographic atrophy: a review
Desai, D., & Dugel, P. U. (2022) · Eye · doi:10.1038/s41433-021-01765-x · Cited by 79
Common Eye Diseases of Elderly People: Identifying and Treating Causes of Vision Loss
Harvey, P. T. (2002) · Gerontology · doi:10.1159/000066507 · Cited by 78
New treatments in age‐related macular degeneration
Hooper, C., & Guymer, R. H. (2003) · Clinical and Experimental Ophthalmology · doi:10.1046/j.1442-9071.2003.00683.x · Cited by 74
Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
Askou, A. L., Alsing, S., Benckendorff, J. N. E., Holmgaard, A., Mikkelsen, J. G., Aagaard, L., Bek, T., & Corydon, T. J. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.01.012 · Cited by 64 · cited 1×
“A new discovery of gene therapy, dual acting therapy provides promising results in the treatment of nAMD [17].”
BackgroundGene therapy for age-related macular degeneration
Moore, N. A., Bracha, P., Hussain, R. M., Morral, N., & Ciulla, T. A. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1356817 · Cited by 63
Issues with Intravitreal Administration of Anti-VEGF Drugs
Schargus, M., & Фрингс, А. (2020) · Clinical ophthalmology · doi:10.2147/opth.s207978 · Cited by 62
Age-related macular degeneration: current treatment and future options
Moutray, T., & Chakravarthy, U. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311415895 · Cited by 37
Research works printed but not linked: 1
- Dugel PU, 2020, Retinalphysician.com
Cited by
Hakim, A. M., Guido, B., Narsineni, L., Chen, D.-W., & Földvári, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114781 · Cited by 56
Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age
Clare, A. J., Langer, P. M., Ward, A., Chan, Y. K., Dick, A. D., & Copland, D. A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.028 · Cited by 19
Nanotechnology for vision restoration
Lanzani, G., Chiaravalli, G., Colombo, E., Manfredi, G., Marco, S. D., Vurro, V., & Benfenati, F. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00210-4 · Cited by 19
Metadata
- Authors
- Khan, H., Khan, H., Aziz, A. A., Ewing, T., & Khanani, A. M.
- Affiliations
- University of Nevada, Reno (US)
- Sierra Eye Associates (US)
- Corresponding author
- Khanani, Arshad M.
- Venue
- Expert Review of Ophthalmology
- Publisher
- Informa UK Limited
- Published
- 2022-11-02
- Volume
- 17
- Issue
- 6
- Pages
- 371-374
- ISSN
- 1746-9899 (ISSN-L)
- 1746-9902
- OpenAlex
- W4308971187
- Cited by
- 3
- References
- 11
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Expert Review of Ophthalmology (publishedVersion)
- Funders
- funding
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related macular degeneration, gene therapy, neovascular AMD, vision loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How could gene therapy change the way we treat age-related macular degeneration? https://app.cochat.ai/papers/10.1080/17469899.2022.2147927
- The paper
- Khan, H., Khan, H., Aziz, A. A., Ewing, T., & Khanani, A. M. (2022). How could gene therapy change the way we treat age-related macular degeneration? Expert Review of Ophthalmology. https://doi.org/10.1080/17469899.2022.2147927
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.